Rewatch the Post EHA & ICLM 2023 meeting
Post EHA & ICML 2023
On Thursday 21 September 2023, Esteemed Belgian experts in hematology explored the practical applications of the latest findings in hematology from EHA & ICML 2023. How will these new data change current guidelines? This dynamic and interactive session provides valuable insights for your daily practice.
Presentation 1: Michel Delforge
Prof dr Michel Delforge from UZ Leuven gives a nice overview of recent developments in the management of relapsed multiple myeloma.
Presentation 2: Lucien Noens
Prof em Lucien Noens from UZ Ghent sheds his light on updates in acute myeloid leukemia (AML). He focuses amongst others on the heterogeneity of AML, clonal hematopoiesis, the relevance of minimal residual disease, and potential new treatment options for acute leukemias.
Presentation 3: Ann Janssens
Prof dr Ann Janssens from UZ Leuven discusses the management of fit and unfit chronic lymphocytic leukemia (CLL) patients based on recent findings from the EHA and ICML congresses.
Presentation 4: Dominique Bron
As a follow-up to Prof Janssens’ presentation, Prof em Dominique Bron from Jules Bordet Institute, Brussels continues on the management of fit and unfit chronic lymphocytic leukemia (CLL) patients based on recent findings from the EHA and ICML congresses.
This meeting was made possible with the educational support of:
